Reducing Complexity in Starting Clinical
Trials – More Patients, Faster Startup
Sponsored by Oracle Health Sciences
Tuesday, Jan. 26, 2021 | 1:00 p.m. EST | 10:00 a.m. PST
Location: Your office or conference room (no need to travel!)
As clinical trials continue to grow in complexity, take longer to initiate, and suffer from patient under-enrollment, stakeholders have an increasingly urgent need to improve clinical trial efficiencies and outcomes. Enhancing communication and collaboration with sites is vital in helping sponsors and CROs bring new treatments to market faster. This is especially critical in a climate permanently transformed by COVID-19.
The Integration of study startup workflows, and predictive analytics capabilities from Oracle with Cognizant’s site-centric Shared Investigator Platform’s (SIP) solutions for virtual monitoring and study oversight, and electronic document exchange and collaboration, enables sites, sponsors, and CROs to adapt to the new normal of conducting clinical trials virtually.
The collaboration between Cognizant and Oracle eliminates redundancy for sites and delivers better outcomes for sponsors and CROs. In this webcast, we will explore how our collaboration:
- Reduces study startup cycle times by harmonizing processes and common documents across studies.
- Automates workflows for the management of contacting sites and collecting site documentation for IRB/EC submissions.
- Increases data reliability, transparency, and regulatory compliance
- Simplifies and optimizes clinical trials, driving productivity gains
- Enables transparent and enhanced communications and collaborations with sponsor/CRO study teams
- Reduces the study burden on sites by utilizing a centralized site profile that is maintained by the site and leveraged across multiple studies by sponsors/CROs.
This webcast is applicable to:
- Sponsor and CRO roles who are responsible for:
- Site identification, feasibility assessment, selection and activation
- Clinical data management, collecting and evaluating trial metrics
- Project management of studies and operational excellence
- Investigative site roles responsible for the patient engagement in clinical trials
Meet Your PresenterS:
Director of Research, Holston Medical Group, and Board of Trustees
Dr. Morin is currently the Director of Research for Holston Medical Group, a large physician-owned multispecialty practice in the US (TN, VA, & NC). He has over 30 years of experience as a clinical researcher, practicing physician, and educator. A past recipient of the ‘Outstanding Physician Leadership in the Profession’ award by ACRP, he currently serves on their Board of Trustees. He developed SiteOptex® Software to maximize efficiency at research sites by measuring the impact of cumulative complexity on productivity and has published numerous articles on this novel technology, most recently in DIA’s journal — TIRS. Past activities include clinical teaching faculty for ETSU College of Medicine, Employee Health Director for a large hospital system, Medical Director of a CRO, an ACO (Qualuable), and as Chief Medical Officer for the national E-Health and Bio-Surveillance system in Ghana, Africa.
Vice President, Site Engagement
The Society of Clinical Research Sites (SCRS)
Jimmy Bechtel is the Society for Clinical Research Sites' (SCRS) Vice President, Site Engagement. He brings experience from both the site and sponsor sides of the clinical research industry to his critical role with SCRS. Jimmy provided a variety of support within the site spectrum in previous positions as data specialist, patient recruiter and operations manager. On the pharma side where he worked in innovation project management, Jimmy utilized his previous professional experience to encourage a site-centric environment and create ease for sites working with a major sponsor company. This multifaceted background allows Jimmy to bring a unique perspective to the work he does on behalf of the sites. At SCRS, Jimmy is in charge of developing and executing the company's site-facing initiatives, and works closely with key industry partners to build out various SCRS partnership programs. Additionally, Jimmy oversees the Membership department operations as well as design and marketing.
Professor of Medicine (Medical Oncology); Professor of Medicine; Associate Cancer Center Director of Experimental Therapeutics, Yale Cancer Center
Yale School of Medicine
Pat LoRusso brings more than 25 years of expertise in medical oncology, drug development, and early phase clinical trials. Prior to her Yale appointment, she served in numerous leadership roles at Wayne State University’s Barbara Karmanos Cancer Institute, most recently as director of the Phase I Clinical Trials Program and of the Eisenberg Center for Experimental Therapeutics.
Product Lead for the Cognizant Shared Investigator Platform (SIP)
Cognizant Healthcare and Life Sciences
Larissa Comis is a clinical trial technology expert with nearly 20 years in the Life Sciences, Healthcare and Software/Technology industries, with a focus in oncology. She has worked with all constituents in the life sciences industry including life sciences professionals, patients, doctors, nurses and payers. Her work has included developing and implementing go-to-market strategies globally, including for Thomson Reuters Cortellis Clinical Trials Intelligence and for Medidata Solutions where she was Sr. Director of Platform Strategy and Value. She has also worked with the National Cancer Institute on several national clinical trial technology initiatives, including working with investigators to select a national electronic data capture platform. Currently, Larissa is the Product Lead for the Cognizant Shared Investigator Platform (SIP). Larissa holds a BA from William Smith College and a Master of Journalism from Temple University.
Global Vice President of Product
Oracle Health Sciences
Sujay has over 20 years of experience building leading software solutions focused within life sciences. Prior to Oracle he was the CEO of goBalto where he grew and commercialized the startup into a fast-growing market leader in the study startup area. Prior to goBalto, Sujay was an early executive at Model N (NYSE MODN) the leader in revenue management software. He ran the life sciences business during the critical growth years and helped grow business from pre-revenue to its eventual IPO in 2013. In his 20 years, he has had a strong track record of building market-leading products in hyper-growth segments.